Lipoprotein analysis by differential charged-particle mobility
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G01N-015/02
G01N-033/92
C07K-001/14
G06F-019/10
출원번호
US-0226089
(2014-03-26)
등록번호
US-9046539
(2015-06-02)
발명자
/ 주소
Caulfield, Michael P.
Reitz, Richard E
Li, Shuguang
Lee, Gloria Kwangja
Krauss, Ronald
Blanche, Patricia J.
Benner, W. Henry
Cornell, Earl
출원인 / 주소
QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
대리인 / 주소
Foley & Lardner LLP
인용정보
피인용 횟수 :
0인용 특허 :
30
초록▼
The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoprotein
The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention.
대표청구항▼
1. A method for purifying lipoproteins for differential charged particle mobility analysis, said method comprising: a) incubating a solution comprising lipoproteins, non-lipoproteins, dextran sulfate and a solid support comprising a paramagnetic particle, under conditions for said lipoproteins to bi
1. A method for purifying lipoproteins for differential charged particle mobility analysis, said method comprising: a) incubating a solution comprising lipoproteins, non-lipoproteins, dextran sulfate and a solid support comprising a paramagnetic particle, under conditions for said lipoproteins to bind to said solid support;b) isolating said solid support from the solution thereby separating said lipoproteins from said non-lipoproteins; andc) releasing said lipoproteins from said solid support, wherein said released lipoproteins are suitable for differential charged particle mobility analysis that determines size distribution of said lipoproteins;and d) subjecting said lipoproteins to differential charged particle mobility analysiswherein: said lipoproteins comprise HDL and one or more selected from the group consisting of LDL, Lp(a), IDL and VLDL; andsaid method does not include centrifugation. 2. The method according to claim 1, wherein said solid support comprises a bead. 3. The method according to claim 1, wherein said solid support comprises a lipoprotein-capture ligand capable of binding lipoproteins. 4. The method according to claim 3, wherein said lipoprotein-capture ligand is selected from the group consisting of an aptamer and an antibody. 5. The method according to claim 1, wherein subjecting said lipoprotein to differential charged particle mobility analysis comprises: determining a differential mobility particle size distribution in one or more regions of particle sizes for said lipoproteins;subtracting contribution to the particle size distribution of a non-lipoprotein reagent or a non-lipoprotein sample material to obtain a lipoprotein particle size distribution; andoutputting the lipoprotein particle size distribution to a display, a printer or a memory. 6. The method according to claim 5, wherein the determining a particle size distribution includes determining a best fit for the one or more regions. 7. The method according to claim 6 wherein the best fit is of the form: y1=k1*e(−0.7*d);where y1 is a contribution to the measured differential mobility size distribution, k1 is an empirical constant of the fit, and d is particle diameter;wherein the determining a best fit includes calculating a value for k1. 8. The method according to claim 5, wherein the subtracting includes applying a theoretical curve representing particle size distribution of the non-lipoprotein reagent or the non-lipoprotein sample material. 9. The method according to claim 5, wherein the non-lipoprotein reagent is Reactive Green 19 conjugated with dextran (RGD). 10. The method according to claim 5, wherein the non-lipoprotein sample material is albumin. 11. A method for purifying lipoproteins for differential charged particle mobility analysis, said method comprising: a) incubating a solution comprising lipoproteins, non-lipoproteins, dextran sulfate and a solid support comprising a paramagnetic particle, under conditions for said lipoproteins to bind to said solid support;b) isolating said solid support from the solution thereby separating said lipoproteins from said non-lipoproteins;c) releasing said lipoproteins from said solid support;d) subjecting said lipoproteins to differential charged particle mobility analysis that comprises: determining a differential mobility particle size distribution in one or more regions of particle sizes for said lipoproteins; andsubtracting contribution to the particle size distribution of a non-lipoprotein reagent or a non-lipoprotein sample material to obtain a lipoprotein particle size distribution; andoutputting the lipoprotein particle size distribution to a display, a printer or a memory;wherein: said lipoproteins comprise HDL and one or more selected from the group consisting of LDL, Lp(a), IDL and VLDL, andthe determining a differential mobility particle size distribution includes determining a best fit for the one or more regions. 12. The method according to claim 11, wherein said method does not include centrifugation. 13. The method according to claim 11, wherein said solid support comprises a bead. 14. The method according to claim 11, wherein said solid support comprises a lipoprotein-capture ligand capable of binding lipoproteins. 15. The method according to claim 14, wherein said lipoprotein-capture ligand is selected from the group consisting of an aptamer and an antibody. 16. The method according to claim 11 wherein the best fit is of the form: y1=k1*e(−0.7*d);where y1 is a contribution to the measured differential mobility size distribution, k1 is an empirical constant of the fit, and d is particle diameter;wherein the determining a best fit includes calculating a value for k1. 17. The method according to claim 11, wherein the subtracting includes applying a theoretical curve representing particle size distribution of the non-lipoprotein reagent or the non-lipoprotein sample material. 18. The method according to claim 11, wherein the non-lipoprotein reagent is Reactive Green 19 conjugated with dextran (RGD). 19. The method according to claim 11, wherein the non-lipoprotein sample material is albumin.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (30)
Koren Eugen ; Koscec Mirna, Antibodies to lipoproteins and apolipoproteins and methods of use thereof.
Hairston Peter P. (St. Paul MN) Dorman Frank D. (Golden Valley MN) Sem Gilmore J. (Lauderdale MN) Agarwal Jugal K. (New Brighton MN), Apparatus for measuring particle sizes and velocities.
Griffin Linda ; Albrecht Glenn ; Latham John ; Leung Lawrence ; Vermaas Eric ; Toole John J., Aptamers specific for biomolecules and methods of making.
Kaufman Stanley L. (New Brighton MN) Zarrin Fahimeh (St. Paul MN) Dorman Frank (Minneapolis MN), Electrospray apparatus for producing uniform submicrometer droplets.
Otvos James D. (1827 E. Kenmore Pl. Shorewood WI 53211), Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer.
Zarrin Fahimeh (St. Paul MN) Kaufman Stanley L. (Minneapolis MN) Dorman Frank D. (Golden Valley MN), Method and apparatus for determining concentration of macromolecules and colloids in a liquid sample.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.